Tom Reeves

Tom Reeves is an accomplished executive with extensive experience in leading various organizations within the biotechnology and technology sectors. Currently serving as President and CEO at Ripple Therapeutics since January 2020, Tom also holds board member positions at Soricimed Biopharma Inc. and Medcan Clinic. Previous roles include President and CEO at Interface Biologics and Borderfree, as well as President and COO at OccuLogix, Inc. Tom's impressive career began at Merisel, where notable positions included Managing Director for Merisel Europe and President roles across Canada. Educational credentials include a BA in Economics from Harvard University and an MA in International Relations from The Australian National University.